These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31489065)

  • 1. Association between highly active antiretroviral therapy (HAART) and hypertension in persons living with HIV/AIDS at the Bamenda regional hospital, Cameroon.
    Pangmekeh PJ; Awolu MM; Gustave S; Gladys T; Cumber SN
    Pan Afr Med J; 2019; 33():87. PubMed ID: 31489065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
    Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
    PLoS One; 2016; 11(2):e0148100. PubMed ID: 26862763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study.
    Namme Luma H; Doualla MS; Choukem SP; Temfack E; Ashuntantang G; Achu Joko H; Koulla-Shiro S
    Pan Afr Med J; 2012; 12():87. PubMed ID: 23077708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
    Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
    PLoS One; 2016; 11(5):e0155560. PubMed ID: 27195956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIVinfected Persons.
    Adedeji TA; Adebisi SA; Adedeji NO
    Infect Disord Drug Targets; 2020; 20(3):374-384. PubMed ID: 31389318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors of severe hepatotoxicity among HIV-1 infected individuals initiated on highly active antiretroviral therapy in the Northwest Region of Cameroon.
    Abongwa LE; Nyamache AK; Charles F; Torimiro J; Emmanuel N; Domkam I; Eyongetah M; Jude B; Mua FH; Bella S; Tamboh TC; Moungang EC; Ngum V; Okemo P
    BMC Gastroenterol; 2022 Jun; 22(1):286. PubMed ID: 35658835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Highly Active Antiretroviral Therapy on Renal Function and Renal Phosphate Handling in African Adults with Advanced HIV and CKD.
    Adedeji TA; Adebisi SA; Adedeji NO; Biliaminu SA; Olanrewaju TO
    Infect Disord Drug Targets; 2019; 19(1):88-100. PubMed ID: 30027856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of dyslipidemia on PLHIV associated with different antiretroviral regimens in Huzhou.
    Wang Y; Yang Z; Li J; Wu Z; Liu X; Wang H; Chen Y; Wang Z; Tong Z; Li X; Ren F; Jin M; Mao G
    PLoS One; 2024; 19(9):e0305461. PubMed ID: 39302927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients].
    Li WJ; Dai Y; Han Y; Qiu ZF; Xie J; Zuo LY; Li YL; Li TS
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1318-22. PubMed ID: 21756757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
    Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
    BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and associated factors of treatment failure among HIV/AIDS patients on HAART attending University of Gondar Referral Hospital Northwest Ethiopia.
    Ayele G; Tessema B; Amsalu A; Ferede G; Yismaw G
    BMC Immunol; 2018 Dec; 19(1):37. PubMed ID: 30558580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The magnitude of hypertension and associated factors among clients on highly active antiretroviral treatment in Southern Ethiopia, 2020: A hospital-based cross-sectional study.
    Lukas K; Markos E; Belayneh F; Habte A
    PLoS One; 2021; 16(10):e0258576. PubMed ID: 34653207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients.
    Palacios R; Santos J; García A; Castells E; González M; Ruiz J; Márquez M
    HIV Med; 2006 Jan; 7(1):10-5. PubMed ID: 16313287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of first-line combination antiretroviral therapy with malaria among adult HIV-infected persons in Jos, Nigeria: a pilot cross sectional study.
    Onukak A; Aninagyei E; Ekuma A; Gomerep S; Shehu N; Isa S
    BMC Infect Dis; 2024 Sep; 24(1):1038. PubMed ID: 39333924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study.
    Ankrah DNA; Lartey M; Mantel-Teeuwisse AK; Leufkens HGM
    BMC Infect Dis; 2017 Oct; 17(1):664. PubMed ID: 28969591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of cardio-vascular diseases among highly active antiretroviral therapy (HAART) treated HIV seropositive volunteers at a treatment centre in Lagos, Nigeria.
    Ekun OA; Fasela EO; Oladele DA; Liboro GO; Raheem TY
    Pan Afr Med J; 2021; 38():206. PubMed ID: 33995812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension among people living with HIV/AIDS in Cameroon: A cross-sectional analysis from Central Africa International Epidemiology Databases to Evaluate AIDS.
    Dzudie A; Hoover D; Kim HY; Ajeh R; Adedimeji A; Shi Q; Pefura Yone W; Nsame Nforniwe D; Thompson Njie K; Pascal Kengne A; Ebasone PV; Barche B; Bissek Anne Cecile ZK; Nash D; Yotebieng M; Anastos K
    PLoS One; 2021; 16(7):e0253742. PubMed ID: 34292956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting.
    Kalyesubula R; Kagimu M; Opio KC; Kiguba R; Semitala CF; Schlech WF; Katabira ET
    Afr Health Sci; 2011 Mar; 11(1):16-23. PubMed ID: 21572852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.
    Sax PE; Tierney C; Collier AC; Daar ES; Mollan K; Budhathoki C; Godfrey C; Jahed NC; Myers L; Katzenstein D; Farajallah A; Rooney JF; Ha B; Woodward WC; Feinberg J; Tashima K; Murphy RL; Fischl MA;
    J Infect Dis; 2011 Oct; 204(8):1191-201. PubMed ID: 21917892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coprevalence and associations of diabetes mellitus and hypertension among people living with HIV/AIDS in Cameroon.
    Ebasone PV; Dzudie A; Peer N; Hoover D; Shi Q; Kim HY; Brazier E; Ajeh R; Yotebieng M; Nash D; Anastos K; Kengne AP
    AIDS Res Ther; 2024 Jun; 21(1):36. PubMed ID: 38824579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.